Drug Pipeline

Epclusa Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
1
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT03520660 People With CHC Who Achieved a Sustained Virological Response Following Therapy With… Diabetes Mellitus Active, Not Recruiting
Phase 3
NCT07037277 C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV HEPATITIS C VIRUS CHRONIC INFECTION Recruiting
Phase 2
NCT03383419 Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals… Heart Failure Recruiting
Early Phase 1
NCT03112044 Lung Transplant HCV, Pilot Study Lung Transplant Infection Active, Not Recruiting
Sponsors Running Epclusa Trials
University Health Network, Toronto (1) Baylor Research Institute (1) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) Atea Pharmaceuticals, Inc. (1)
Disease Areas
Heart Failure (1) Heart Disease (1) Diabetes (1)
Get alerts when Epclusa trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free